Healthcare
Kester nets 8x on Avania exit to Astorg
Medical device CRO is Astorg's first healthcare deal from its EUR 1.3bn Mid-Cap fund
The Bolts-Ons Digest – 17 June 2022
Unquote’s selection of the latest add-ons with Holland's AMP, Triton's Kinios, Nordic's Sortera, Vitruvian's Sykes, and more
LGT Capital closes first dedicated impact fund on USD 550m
Crown Impact will make co-investments, as well as primary and secondary fund investments
Nexxus Iberia nets 4.2x on Bienzobas exit to trade
Sale of oncology group marks GP's second exit from debut fund; buyer Atrys pays 8.5x EBITDA
Gimv launches life sciences investment platform
Sponsor seeks to double portfolio and invest bigger tickets in drug development companies
Hg exits Medifox Dan to trade for EUR 950m, nets 4x return
Houlihan-Lokey led auction attracted large-cap sponsors such as BC Partners, Warburg Pincus and Permira
Clearwater Multiples Heatmap: PE activity holds up amid war, inflation woes
Record levels of dry powder continue to bolster the resilience of the buyout market in Q1 2022
Main Capital on the road for debut growth fund with more fundraises in sight
New vintage of existing strategies and a healthcare-focused continuation fund are also on the agenda for the software-focused GP, according to founding partner and CEO Charly Zwemstra
Synergia plans EUR 200m Fund VI final close by end of 2022
GP is targeting family offices and entrepreneurs and aims to hold a EUR 150m first close by the end of June
Unigestion launches third Direct fund with EUR 1bn target
Strategy invests in mid-market companies alongside the GP's investment partner network
Forbion exceeds Growth Opportunities II target with EUR 470m first close
Biopharma GP sees growing demand for private capital amid IPO lull; gears up for EUR 600m hard-cap by summer end
Axcel exits European Sperm Bank to Perwyn
Deal is the fourth exit for Axcel's fifth fund; buyer Perwyn deploys evergreen capital
SGT Capital at halfway point of USD 2bn fundraising ambition
USD 800m first closing coincides with regulatory approval for Utimaco acquisition
Astorg buys Open Health in SBO from Amulet
The medical communications company was Amulet's only asset outside of North America
Bridgepoint acquisition of Dentego collapses
GP had entered into exclusive negotiations with vendor G Square following a Lazard-led process
Livingbridge taps PwC to explore Helping Hands exit
GP acquired the UK-based home care provider from its founders in 2018 in a Deloitte-led auction
FSN Capital acquires Epista Life Sciences
The GP said it will pursue a buy-and-build strategy in the life science IT services sector
Advent Life Sciences hires three partners
Dominic Schmidt is based in the UK, while Satish Jindal and Katrine Bosley join in the US
Five Arrows kicks off Laf Santé sale
Five Arrows has owned a majority stake in the France-based low-cost pharmacy chain since 2016
Hg's MEDIFOX sale launch draws large-cap sponsor interest
Hg acquired the software platform for care providers in 2018 from ECM Equity Capital Management
Goldman Sachs AM beats sponsors to buy Norgine
Buyer's PE arm competed with Bain and Cinven in the auction second round
Cathay Capital launches EUR 500m health fund
New vehicle will invest at the crossover of health care, life sciences and tech with EUR 5m-50m tickets
Sovereign Capital readies Nurse Plus for exit
Clearwater International hired to advise on sale of the UK-based healthcare staff agency
Advent raises USD 25bn for GPE X
Around 40% larger than its predecessor, the new fund was raised in less than six months, managing director Johanna Barr tells Unquote